| Dr David Lee Hinkamp, MD | |
|
1901 W Harrison St, Chicago, IL 60612-3714 | |
| (312) 864-6000 | |
| Not Available |
| Full Name | Dr David Lee Hinkamp |
|---|---|
| Gender | Male |
| Speciality | Preventive Medicine - Public Health & General Preventive Medicine |
| Location | 1901 W Harrison St, Chicago, Illinois |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1629090089 | NPI | - | NPPES |
| Entity Name | Cook County |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588612832 PECOS PAC ID: 2860398088 Enrollment ID: O20031209000747 |
News Archive
UnitedHealthcare, a UnitedHealth Group company, said its Military & Veterans Services business unit has been awarded the Department of Defense's TRICARE Managed Care Support contract to provide health care services for active duty and retired military service members and their families in the West Region.
Oxford University doctors and scientists are performing the second phase of clinical studies of an experimental Ebola vaccine regimen. The study is part of the EBOVAC2 project, a collaborative programme involving the University of Oxford, French Institute of Health and Medical Research as project coordinator, London School of Hygiene & Tropical Medicine, Le Centre Muraz, Inserm Transfert and the Janssen Pharmaceutical Companies of Johnson & Johnson.
Innovent Biologics, Inc., a privately held Chinese biopharmaceutical company dedicated to the development and manufacturing of complex, high-end biologics to be marketed in the rapidly growing Chinese market and elsewhere worldwide that meet EMEA and FDA/cGMP standards, has raised $100 million in Series C financing.
Most people have never heard of mastocytosis. It's a rare, sometimes deadly, immune disorder. Now new research may help those with advanced mastocytosis and possibly many more people, too.
Upsher-Smith Laboratories, Inc. presented data from a 52-week, open-label extension study (PREVAIL OLE) showing that Qudexy XR (topiramate) extended-release capsules offered a long-term adjunctive treatment option with a favorable tolerability profile for a high proportion of patients with refractory partial-onset seizures (POS).
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr David Lee Hinkamp, MD 4071 N Broadway St, Suite #1, Chicago, IL 60613-2117 Ph: (773) 935-7431 | Dr David Lee Hinkamp, MD 1901 W Harrison St, Chicago, IL 60612-3714 Ph: (312) 864-6000 |
News Archive
UnitedHealthcare, a UnitedHealth Group company, said its Military & Veterans Services business unit has been awarded the Department of Defense's TRICARE Managed Care Support contract to provide health care services for active duty and retired military service members and their families in the West Region.
Oxford University doctors and scientists are performing the second phase of clinical studies of an experimental Ebola vaccine regimen. The study is part of the EBOVAC2 project, a collaborative programme involving the University of Oxford, French Institute of Health and Medical Research as project coordinator, London School of Hygiene & Tropical Medicine, Le Centre Muraz, Inserm Transfert and the Janssen Pharmaceutical Companies of Johnson & Johnson.
Innovent Biologics, Inc., a privately held Chinese biopharmaceutical company dedicated to the development and manufacturing of complex, high-end biologics to be marketed in the rapidly growing Chinese market and elsewhere worldwide that meet EMEA and FDA/cGMP standards, has raised $100 million in Series C financing.
Most people have never heard of mastocytosis. It's a rare, sometimes deadly, immune disorder. Now new research may help those with advanced mastocytosis and possibly many more people, too.
Upsher-Smith Laboratories, Inc. presented data from a 52-week, open-label extension study (PREVAIL OLE) showing that Qudexy XR (topiramate) extended-release capsules offered a long-term adjunctive treatment option with a favorable tolerability profile for a high proportion of patients with refractory partial-onset seizures (POS).
› Verified 5 days ago
Dr. Anne Judith Krantz, M.D. Preventive Medicine Medicare: Accepting Medicare Assignments Practice Location: 1901 W Harrison St, Chicago, IL 60612 Phone: 312-864-6000 | |
Michelle Theresa Watters, MD Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 2121 W Taylor St, Sph/eohs, Occ. Med., Mc 684, Chicago, IL 60612 Phone: 312-413-0369 | |
Elijah Ezeofor, Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 2133 W Lexington St, 2nd Floor Chicago Dept. Of Public Helath, Chicago, IL 60612 Phone: 312-746-4664 Fax: 312-746-6526 | |
Dr. Patrick Mccafferty Lank, M.D. Preventive Medicine Medicare: Medicare Enrolled Practice Location: 211 E Ontario St, Suite 200, Chicago, IL 60611 Phone: 312-926-6494 | |
Dr. Lourdes Mella Hilao, M.D. Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 4243 W Fullerton Ave, Chicago, IL 60639 Phone: 773-489-5110 Fax: 773-489-5111 | |
Armando Salinas, Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 2133 W Lexington St, Chicago, IL 60612 Phone: 312-746-5050 Fax: 312-746-6526 | |
Dr. Martin W Harrison, MD Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 1318 W Catalpa Ave, Chicago, IL 60640 Phone: 312-972-6070 |